Skip to main content

Table 4 Recently started antihypertensive drugs; comparison of number of hip fractures during exposed and unexposed person-timea

From: Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study

  Total cohort By sex
Exposed person-days (14 days)    Women Men
  n SIR (CI) n SIR (CI) n SIR (CI)
Thiazide 16 0.9 (0.5–1.5) 12 0.9 (0.5–1.6) 4 0.8 (0.2–2.2)
Loop diuretic 104 1.5 (1.3–1.9) 76 1.6 (1.2–2.0) 28 1.5 (1.0–2.1)
Beta blocker 47 1.0 (0.7–1.3) 32 1.0 (0.7–1.3) 15 1.0 (0.6–1.6)
Calcium channel blocker 38 1.0 (0.7–1.4) 30 1.1 (0.7–1.5) 8 0.8 (0.3–1.5)
ACE inhibitor 29 1.0 (0.7–1.5) 24 1.3 (0.8–1.9) 5 0.5 (0.2–1.2)
ACE inhibitor/Thiazide 2 0.4 (0.1–1.6) 2 0.6 (0.1–2.2) 0
Angiotensin II receptor blocker 11 1.0 (0.5–1.8) 11 1.0 (0.5–1.8) 0
Angiotensin II receptor blocker/Thiazide 10 0.5 (0.2–0.9) 8 0.5 (0.2–1.1) 2 0.4 (0–1.4)
  1. SIR Standardized Incidence Ratio
  2. aThe population of Norway born before 1945 and exposed to various antihypertensive drugs in 2005–2010 after 365 days wash out (exposed person-days, 14 days)